Literature DB >> 10874154

Hypomethylation as a cause of homocysteine-induced cell damage in human cell lines.

B Hultberg1, A Andersson, A Isaksson.   

Abstract

Despite the growing evidence that plasma homocysteine is a cardiovascular risk factor, the mechanism behind the vascular injuries is still unknown. In the present study we have investigated the possible role of hypomethylation as a cause of homocysteine-induced cell damage in two human cell lines. A significant growth retardation was observed in HeLa cell cultures in the combined presence of homocysteine and adenosine, but first at concentrations of 250 micromol/l of each. A significant decrease of intracellular glutathione concentration was noted both in the presence of homocysteine (250 micromol/l) alone and in the presence of the combination of homocysteine and adenosine (250 micromol/l). Intracellular concentration of homocysteine was increased to a similar extent both in the presence of homocysteine alone and in the presence of a combination of homocysteine and adenosine. Similar findings to those described for HeLa cell cultures were observed in endothelial cell cultures. Furthermore, in the presence of copper ions together with 100 micromol/l of adenosine and homocysteine a significantly retarded cell growth was observed in HeLa cell cultures. This finding shows that a combination of two potentially cell-damaging mechanisms (formation of oxygen radicals and hypomethylation) aggravated the retardation of cell growth compared to only one of these mechanisms being present. Thus, it is likely that several mechanisms of homocysteine-induced cell damage contribute to the increased rate of the atherogenic process observed in hyperhomocysteinemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874154     DOI: 10.1016/s0300-483x(00)00189-x

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  5 in total

1.  Effect of physical exercise on thiols in the plasma in the athletic horse: connection with the immune system.

Authors:  L Avellini; E Chiaradia; L Terracina; A Gaiti
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

2.  Homocysteine pre-treatment increases redox capacity in both endothelial and tumor cells.

Authors:  Elena Díaz-Santiago; Luis Rodríguez-Caso; Casimiro Cárdenas; José J Serrano; Ana R Quesada; Miguel Ángel Medina
Journal:  Redox Rep       Date:  2016-05-19       Impact factor: 4.412

3.  Homocysteine is a potent modulator of plasma membrane electron transport systems.

Authors:  Javier Rodríguez-Alonso; Raúl Montañez; Luis Rodríguez-Caso; Miguel Angel Medina
Journal:  J Bioenerg Biomembr       Date:  2008-01-24       Impact factor: 2.945

4.  Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain.

Authors:  Chang-E Zhang; Wei Wei; Ying-Hua Liu; Jun-Hua Peng; Qing Tian; Gong-Ping Liu; Yao Zhang; Jian-Zhi Wang
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

5.  Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age.

Authors:  Krista S Crider; Eoin P Quinlivan; Robert J Berry; Ling Hao; Zhu Li; David Maneval; Thomas P Yang; Sonja A Rasmussen; Quanhe Yang; Jiang-Hui Zhu; Dale J Hu; Lynn B Bailey
Journal:  PLoS One       Date:  2011-12-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.